Egetis Therapeutics AB (publ) (STO:EGTX)
Sweden · Delayed Price · Currency is SEK 9.90
-0.16 (-1.59%)
Nov 2, 2026, 5:24 PM CET
Egetis Therapeutics AB Market Cap
Egetis Therapeutics AB has a market cap or net worth of 4.68 billion as of November 2, 2026. It is the 14,592nd most valuable company in the world and the 189th biggest in Sweden. Its market cap has increased by 79.34% in one year.
Market Cap
4.68B
Enterprise Value
4.37B
Revenue
66.00M
Global Rank
Country Rank
#189 Sweden
PE Ratio
n/a
ChartMarket Cap Chart
Since April 7, 2011, Egetis Therapeutics AB's market cap has increased from 224.89M to 4.68B, an increase of 1,979.84%. That is a compound annual growth rate of 21.50%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 2, 2026 | 4.68B | 121.66% |
| Dec 30, 2025 | 2.11B | -16.09% |
| Dec 30, 2024 | 2.51B | 54.03% |
| Dec 29, 2023 | 1.63B | 7.15% |
| Dec 30, 2022 | 1.52B | 37.56% |
| Dec 30, 2021 | 1.11B | -10.17% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| BioArctic AB | 28.14B |
| Hansa Biopharma AB | 4.00B |
| Vicore Pharma Holding AB | 2.73B |
| Saniona AB | 1.54B |
| Genovis AB (publ.) | 1.46B |
| Flerie AB | 1.21B |
| Medivir AB | 967.26M |
| SynAct Pharma AB | 908.29M |